NewsRamp is a PR & Newswire Technology platform that enhances press release distribution by adapting content to align with how and where audiences consume information. Recognizing that most internet activity occurs outside of search, NewsRamp improves content discovery by programmatically curating press releases into multiple unique formats—news articles, blog posts, persona-based TLDRs, videos, audio, and Zero-Click content—and distributing this content through a network of news sites, blogs, forums, podcasts, video platforms, newsletters, and social media.
FAQ: ADAP Advocacy's 340B Program Commercial and Declining Hospital Charity Care
TL;DR
ADAP Advocacy's campaign exposes how hospitals profit from 340B drug discounts instead of providing charity care, creating an opportunity to advocate for reform and accountability.
The 340B Program requires drug manufacturers to offer discounted medications to eligible hospitals, which are then supposed to use the savings to provide charity care to low-income patients.
Reforming the 340B Program could ensure hospitals use drug discounts to provide charity care, improving healthcare access for low-income and minority communities.
ADAP Advocacy's commercial reveals that 69% of 340B hospitals offer below-average charity care despite receiving drug discounts intended for patient assistance.
Found this article helpful?
Share it with your network and spread the knowledge!
The commercial highlights declining charity care among 340B-eligible hospitals and calls for reforms to the 340B Drug Pricing Program, asking if it has become 'too big to fail.'
ADAP Advocacy is an organization whose mission is to promote and enhance the AIDS Drug Assistance Programs (ADAPs) and improve access to care for persons living with HIV/AIDS.
The commercial highlights that 69% of 340B disproportionate share hospitals offer charity care at a rate below the national average, despite the program's design to help them serve more low-income patients.
Declining charity care disproportionately impacts minority communities and represents a failure of the 340B program's intended purpose of helping hospitals provide free care and financial aid to poor patients.
The 340B Drug Pricing Program is designed for hospitals to provide free care and financial aid to poor patients (charity care) by allowing them to purchase medications from manufacturers at reduced rates.
It is a national advocacy campaign running through the end of the year that highlights hospitals' declining charity care, rising healthcare executive compensation, and exploding patient medical debt.
The commercial is available online at https://youtu.be/7uqGTHT7Zx4.
ADAP Advocacy provides an interactive map that has elevated trends related to declining charity care and other 340B program issues.
For more information about ADAP Advocacy, the 340B Drug Pricing Program, declining hospital charity care, or the new commercial, email info@adapadvocacy.org.
The campaign also addresses rising healthcare executive compensation and exploding patient medical debt among other issues related to the 340B program.
Curated from 24-7 Press Release
